C07J 21/008
At position 17
Official title: {at position 17}
C07J21/008 (At position 17) appears on 123 US grants and 109 published applications in this corpus.
Search patents in C07J- Granted patents
- 123
- Published applications
- 109
- Assignees
- 54
- Inventors
- 213
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 0 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 2 | 5 |
| 2005 | 1 | 2 |
| 2006 | 2 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 3 |
| 2009 | 3 | 2 |
| 2010 | 2 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 4 |
| 2015 | 0 | 5 |
| 2016 | 3 | 7 |
| 2017 | 5 | 10 |
| 2018 | 5 | 5 |
| 2019 | 7 | 10 |
| 2020 | 5 | 10 |
| 2021 | 10 | 12 |
| 2022 | 4 | 4 |
| 2023 | 3 | 9 |
| 2024 | 3 | 8 |
| 2025 | 4 | 5 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neuroactive steroids and methods of use thereof5 May 2026US 12,617,814 B2Sage Therapeutics, Inc.
- Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure23 Dec 2025US 12,503,484 B2Seismic Pharmaceuticals
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- Cyclin-dependent kinase degraders and methods of use10 Jun 2025US 12,325,725 B2Dana-Farber Cancer Institute, Inc.
- Intermediates for the preparation of 11-methylene steroids18 Feb 2025US 12,227,537 B2Crystal Pharma, S.A.U.
- Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure7 May 2026US 2026/0125415 A1Seismic Pharmaceuticals Operations LLC
- Compositions and methods for treating cns disorders9 Apr 2026US 2026/0098053 A1Sage Therapeutics, Inc.
- Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same5 Feb 2026US 2026/0034146 A1Sage Therapeutics, Inc.
- Cyclin-dependent kinase degraders and methods of use28 Aug 2025US 2025/0270252 A1Dana-Farber Cancer Institute, Inc.
- Neuroactive steroids and compositions thereof7 Aug 2025US 2025/0250296 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- 19-Oxygenated-5.alpha.-androstanes for the enhancement of libido91US 4,071,625 ARichardson-Merrell Inc. · 1978
- 17-Hydroxy-steroids72US 4,898,694 A1990
- 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof54US 4,559,332 ACiba-Geigy Corporation · 1985
- Method of treatment of androgen-related diseases48US 5,372,996 AEndorecherche, Inc. · 1994